Search

everythinglearnresearchcommunity

for

Search:↓

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Thyroid function affects skin health, with a complex interaction between the two.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Both treatments for pemphigus foliaceus in dogs are effective, but combination therapy has more side effects.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Immune cells affect hair growth and could lead to new hair loss treatments.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The document suggests that certain protein deficiencies and scalp blistering in Epidermolysis Bullosa may cause hair loss.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.